Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Aequus Pharmaceuticals Inc AQSZF


Primary Symbol: V.AQS

Aequus Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company focused on developing, advancing, and promoting differentiated products. The Company is engaged in the sale and marketing of several commercial products in ophthalmology and transplant. Its pipeline products include Evolve Intensive Gel, Evolve Daily Intensive, SCOPE Portfolio, Zimed PF and REV-0100 / ReVision... see more

TSXV:AQS - Post Discussion

Aequus Pharmaceuticals Inc > New Seeking Alpha report
View:
Post by stockwatch99 on Apr 07, 2021 4:45pm

New Seeking Alpha report

New report available on Seeking Alpha:
https://seekingalpha.com/article/4417929-aequus-pharmaceuticals-new-products-to-accelerate-growth-in-2021

Aequus Pharmaceuticals will be a top stock for this year!
Comment by BlacknBulls on Feb 05, 2022 12:40am
I saw the report also
Comment by WsrThanWenYungr on Feb 17, 2022 11:48am
Only that report is just about a year old now.
Comment by Lisagerrard17 on May 30, 2022 11:58am
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities